Respiratory syncytial virus

American Journal of Nursing

Volumn 104, Issue 11, 2004, Pages 54-56

  Goldrick, Barbara A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; IMMUNOGLOBULIN; RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN INTRAVENOUS;

BRONCHIOLITIS; CHILDHOOD; CHRONIC LUNG DISEASE; CONGENITAL HEART DISEASE; CONVALESCENCE; COUGHING; HIGH RISK POPULATION; HUMAN; IMMUNITY; INCUBATION TIME; INFANCY; INFECTION CONTROL; INFLUENZA; LOWER RESPIRATORY TRACT INFECTION; PNEUMONIA; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SHORT SURVEY; TACHYPNEA; VIRUS INFECTION; VIRUS SHEDDING; VIRUS SURVIVAL; VIRUS TRANSMISSION; WHEEZING; AGED; ARTICLE; CHILD; COMMUNICABLE DISEASE; CROSS INFECTION; DISEASE TRANSMISSION; EPIDEMIC; HOSPITALIZATION; METHODOLOGY; PATIENT SELECTION; PRESCHOOL CHILD; RISK FACTOR; SEASON; STATISTICS; UNITED STATES;

AGED; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; CROSS INFECTION; DISEASE OUTBREAKS; HOSPITALIZATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFECTION CONTROL; PATIENT SELECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS; SEASONS; UNITED STATES; VIRUS SHEDDING;

EID: 10844230148     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200411000-00027     Document Type: Short Survey

References (14)

1. Centers for Disease Control and Prevention. Respiratory syncytial virus. 2003. http://www.cdc.gov/ncidod/dvrd/revb/respiratory/rsvfeat.htm.
2. American Academy of Pediatrics. Respiratory syncytial virus (RSV). 2004. http://www.medem.com/medlb/article_detaillb_ for_printer.cfm?article_ID= ZZZSO05MASD&sub_cat=107.
3. National Library of Medicine. Respiratory syncytial virus (RSV). 2003. http://www.nlm.nih.gov/medlineplus/ency/article/001564.htm.
4. Jones BL, et al. Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults. J Hosp Infect 2000;44(1):53-7.
5. Raad I, et al. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 1997;102(3A):48-52; discussion 3-4.
6. Falsey AR, et al. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc 1992;40(2):115-9.
7. Lowther SA, et al. Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children. Pediatr Infect Dis J 2000;19(1):11-7.
8. Ellis SE, et al. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc 2003;51(6):761-7.
9. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000;13(3):371-84.
10. Han LL, et al. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999;179(1):25-30.
11. Feltes TF, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003;143(4):532-40.
12. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102(3):531-7.
13. Halstead DC, Jenkins SG. Continuous non-seasonal epidemic of respiratory syncytial virus infection in the southeast United States. South Med J 1998;91(5):433-6.
14. Mullins JA, et al. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J 2003;22(10):857-62.